Furthermore, as previously discussed, SNORA38B promotes the secretion of IL-10 by tumor cells, which recruit CD4+FOXP3+ regulatory T cells and reduce CD3+CD8+T cell infiltration in the TME of non-small-cell lung cancer. Here, FOXP3 is linked to non-small cell lung carcinoma.